MedPath

Iodine

Generic Name
Iodine
Brand Names
Sclerodine, Vitafol-one, Xylocaine With Epinephrine
Drug Type
Small Molecule
Chemical Formula
I2
CAS Number
7553-56-2
Unique Ingredient Identifier
9679TC07X4
Background

Iodine is commonly used as an antiseptic for minor cuts and abrasions, preventing infections that may result from contaminated wounds. Additionally, iodine has been studied in the treatment of fibrocystic disease and breast cancer.

Indication

Investigated for use/treatment in breast disorders (unspecified) and pain (acute or chronic).

Associated Conditions
Infection in minor cuts, scrapes, or burns
Associated Therapies
Antimycotic therapy, Antisepsis, Prophylaxis of bacterial skin infections
Clinical Trials
Related News

Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules

Phase 3
Recruiting
Conditions
Radiofrequency Ablation
Thyroid Nodule, Toxic or With Hyperthyroidism
Thyroid Nodule; Hyperthyroidism
Autonomous Thyroid Function
Iodine Hyperthyroidism
Iodine Adverse Reaction
Interventions
Device: Radiofrequency ablation
First Posted Date
2021-12-03
Last Posted Date
2024-08-06
Lead Sponsor
Rijnstate Hospital
Target Recruit Count
232
Registration Number
NCT05142904
Locations
🇳🇱

Laurentius Hospital, Roermond, Limburg, Netherlands

🇳🇱

Elkerliek Hospital, Helmond, Noord-Brabant, Netherlands

🇳🇱

Albert Schweiter Hospital, Dordrecht, Zuid Holland, Netherlands

and more 11 locations

Iodine Supplementation on Breast Cancer

Phase 2
Conditions
Breast Cancer
Interventions
Drug: FEC/TE Placebo
Drug: Placebo
First Posted Date
2018-09-28
Last Posted Date
2018-09-28
Lead Sponsor
Universidad Nacional Autonoma de Mexico
Target Recruit Count
120
Registration Number
NCT03688958
Locations
🇲🇽

Hospital Médico TEC100, Querétaro City, Queretaro, Mexico

🇲🇽

Clínica Hospital Dr. Ismael Vázquez Ortiz ISSSTE, Querétaro, Queretaro, Mexico

🇲🇽

Hospital General Regional #1 IMSS, Querétaro, Queretaro, Mexico

Alcoholic Chlorhexidine Compared to Povidone Iodine to Limit Perineural Catheter Colonisation

Not Applicable
Conditions
Catheter Related Infection
Infection of Catheter Exit Site
Interventions
Procedure: perineural catheterization implementation
First Posted Date
2016-11-01
Last Posted Date
2018-07-18
Lead Sponsor
Hôpital Raymond Poincaré
Target Recruit Count
92
Registration Number
NCT02950246
Locations
🇫🇷

Chu Ambroise Pare, Boulogne-Billancourt, ILE DE France, France

Estimate the Effect of aPDT on Root Canal Disinfection

Not Applicable
Recruiting
Conditions
Root Canal Disinfection
Interventions
Procedure: Rubber dam isolation
Device: aPDT
Drug: 2.5%NaClO
Procedure: root canal preparation
Procedure: root canal obturation
First Posted Date
2016-10-11
Last Posted Date
2022-11-17
Lead Sponsor
Fujian Medical University
Target Recruit Count
40
Registration Number
NCT02929927
Locations
🇨🇳

School and Hospital of stomatology,Fujian Medical University, Fuzhou, Fujian, China

Efficacy of 2% Chlorhexidine Gluconate in 70% Alcohol Compare 10% Povidone Iodine in Blood Culture in Children

Phase 4
Completed
Conditions
Bacteremia
Interventions
First Posted Date
2013-08-09
Last Posted Date
2013-08-13
Lead Sponsor
Thammasat University
Target Recruit Count
1269
Registration Number
NCT01919593
Locations
🇹🇭

Thammasat University hospital, Klong luang, Pathumthanii, Thailand

Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging

Phase 1
Terminated
Conditions
Congestive Heart Failure
Interventions
First Posted Date
2012-01-31
Last Posted Date
2017-04-26
Lead Sponsor
Mayo Clinic
Target Recruit Count
14
Registration Number
NCT01522378
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Does Preoperative Vaginal Preparation With Povidone-iodine Before Cesarean Delivery Reduce the Risk of Endometritis?

Phase 4
Completed
Conditions
Postpartum Endometritis
Interventions
Drug: placebo
First Posted Date
2011-09-20
Last Posted Date
2011-11-17
Lead Sponsor
Erzincan Military Hospital
Target Recruit Count
668
Registration Number
NCT01437228
Locations
🇹🇷

Sisli Etfal Hospital, İstanbul, Sisli, Turkey

The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy

Phase 3
Conditions
Thyroid Neoplasms
Interventions
First Posted Date
2005-06-27
Last Posted Date
2018-03-02
Lead Sponsor
University of Helsinki
Target Recruit Count
160
Registration Number
NCT00115895
Locations
🇫🇮

Helsinki University Central Hospital, Department of Oncology, Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy